Pascale Boissel

John Kozarich has over 40 years of experience in the biopharmaceutical industry and academia. He is Distinguished Scientist Emeritus at ActivX Biosciences, Inc. (La Jolla, CA), an Adjunct Professor in the College of Pharmacy at the University of Texas, Austin. At ActivX, he was Chairman and President from 2004 to 2017 and served in senior management positions since 2001. Dr. Kozarich was Vice President at Merck Research Laboratories (1992-2001) where he was responsible for a variety of drug discovery and development programs and external biotech collaborations. Previously, he held full professorships at the University of Maryland and Yale School of Medicine. He was named a Director of the Year for 2014 by the Corporate Directors Forum for his work at Ligand Pharmaceuticals (LGND), has been an American Cancer Society Faculty Research Awardee, a recipient of the Pfizer Award in Enzyme Chemistry from the American Chemical Society (ACS), the Distinguished Scientist Award of the San Diego Section of the ACS and is a Fellow of the AAAS. Dr. Kozarich currently serves on the Boards of Ligand, Intec Pharma (NTEC) and Curza (Salt Lake City, UT). He holds a B.S. in chemistry from Boston College, a Ph.D. in biological chemistry from the Massachusetts Institute of Technology and was an NIH Postdoctoral Fellow at Harvard University.